Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Diabetic foot Stories

2009-10-23 12:17:00

ADDISON, Texas, Oct. 23 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced that Gregory Bohn, M.D., FACS, Medical Director, Trinity Wound Care and Hyperbaric Medicine, Bettendorf, Iowa, has presented nine clinical posters at the 24th Annual "Clinical Symposium on Advances in Skin and Wound Care" being held in San Antonio, Texas. Highlights of the clinical experience presented by Dr. Bohn's poster presentations include: A stagnated traumatic wound that was...

2009-10-15 08:00:00

SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced the publication of positive findings from the open label multi-center Phase 1/2 clinical study of Excellarate(TM) (GAM501, Ad5PDGF-B / 2.6% collagen), its product candidate for the potential treatment of non-healing diabetic foot ulcers. The clinical findings, entitled Treatment of Nonhealing Diabetic Foot Ulcers with a Platelet-Derived Growth Factor Gene-Activated Matrix (GAM501):...

2009-10-14 08:04:00

SAN DIEGO, Oct. 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced plans for the commercial development of a new product candidate Excellagen(TM), a collagen-based topical gel for use by physicians in conjunction with surgical debridement of wounds in patients with chronic or non-chronic diabetic foot ulcers. This new product opportunity is based on clinical study findings reported today from the Excellarate(TM) Phase 2b clinical study. As reported,...

2009-09-22 20:00:00

IRVINE, Calif., Sept. 22 /PRNewswire/ -- Monarch Labs LLC, the exclusive supplier of Medical Maggots(TM) in the United States, announced today that its Laboratory Director and co-founder, Dr. Ronald Sherman, will attend the Diabetic Limb Salvage conference in Washington, DC, from September 24 to September 26. At Monarch's table display, Dr. Sherman will exhibit the company's Medical Maggots(TM) product (disinfected Phaenicia sericata larvae) and demonstrate this natural therapy to meeting...

2009-09-21 08:00:00

FORT WORTH, Texas, Sept. 21 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today its subsidiary Wound Care Innovations, LLC, will exhibit at the Georgetown University Hospital's Team Approach to Diabetic Limb Salvage (DLS) conference in Washington, D.C. September 24th-26th. The conference, focused on diabetic foot and limb salvage, is expected to be attended by more than 1,000...

2009-09-16 09:00:00

BEIJING, Sept. 16 /PRNewswire-Asia/ -- Fortis Healthcare, one of India's leading private hospital groups, has announced it will broaden inclusion criteria for its upcoming diabetic foot clinical trial. The study will use stem cells derived from peripheral blood to treat critical limb ischemia (diabetic foot). Current treatment of diabetic foot ulcers involves intensive wound management, risk reduction and lengthy rehabilitation. The current treatments available for diabetic foot are both...

2009-08-27 09:00:00

SAN DIEGO, Aug. 27 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported that a recent medical journal article highlights the challenges facing healthcare providers with respect to finding optimal treatments for patients with non-healing wounds. (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO) As reported in the Journal of the American Academy of Physician Assistants, (JAAPA, August 2009), chronic wounds affect an estimated 5.7 million patients...

2009-08-07 08:00:00

SKILLMAN, N.J., Aug. 7 /PRNewswire/ -- ConvaTec, a world-leading provider of innovative medical technologies for community and hospital care, today announced the launch of a new campaign and best practice statement supporting Versiva((R)) XC((R)) gelling foam dressing. Backed up by extensive in vivo and in vitro data, the new campaign shows how healthcare professionals can "Expect More" with Versiva((R)) XC((R)) dressing. The only cover dressing to contain ConvaTec's proprietary...

2009-07-28 08:00:00

SAN DIEGO, Calif., July 28 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) and its subsidiary Tissue Repair Company (TRC) today provided an update on the completion of their MATRIX Phase 2b clinical study and announced plans to provide detailed safety and efficacy data for their Excellarate(TM) product candidate around the end of September. The MATRIX trial, a prospective, randomized, double-blind, placebo-controlled study, has enrolled 124 diabetic patients with...

2009-07-07 08:30:00

FORT WORTH, Texas, July 7 /PRNewswire/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (WNDM.ob), announced today that it will exhibit at the New Cardiovascular Horizons and Management of the Diabetic Foot & Wound Healing (NCVH) conference in New OrleansJuly 9-11. NCVH has become the largest multidisciplinary conference in the country, bringing together cardiologists, surgeons, podiatrists, wound care specialists, family practice physicians,...